Algeria hostage crisis

Algeria hostage crisis

YOKOHAMA, Japan - Takeshi Endo, public relations chief of Japanese engineering firm JGC Corp., holds a press conference at the company's headquarters in Yokohama, near Tokyo, on Jan. 21, 2013, after seven of its employees were confirmed dead following a hostage crisis in Algeria.

  • Product Code
  • ILEA001178933
  • Registered date
  • 2013/1/22 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2013 Kyodo News
  • Media size
  • 2806 × 3872 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 532.59(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Avigan could be formally approved as Ebola drug early 2015

    Avigan could be formally approved as Ebola drug early 2015

    TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus.
      Novartis management replaced

      Novartis management replaced

      TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
        Novartis management replaced

        Novartis management replaced

        TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
          Novartis management replaced

          Novartis management replaced

          TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
            Takeda chief apologizes over data misuse in drug ad

            Takeda chief apologizes over data misuse in drug ad

            TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
              Takeda chief apologizes over data misuse in drug ad

              Takeda chief apologizes over data misuse in drug ad

              TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
                Prosecutors raid Tokuda's Diet office

                Prosecutors raid Tokuda's Diet office

                TOKYO, Japan - Photo shows Takeshi Tokuda, a House of Representatives member and son of Torao Tokuda, former chief of the Tokushukai hospital and welfare business chain. On Nov. 1, 2013, prosecutors raided Tokuda's parliamentary office over an election fraud scandal involving the pair and more than 200 of the chain's employees.
                  Japan Tobacco to undertake drastic restructuring

                  Japan Tobacco to undertake drastic restructuring

                  TOKYO, Japan - Japan Tobacco Co. Vice President Akira Saeki speaks at a news conference in Tokyo on Oct. 30, 2013, as the company said it will close four of its nine cigarette manufacturing-related factories in Japan and a vending machine production base, most of them in March 2015, and cut 1,600 jobs, or about 20 percent of the employees in its tobacco business, due to falling sales.
                    Novartis scandal

                    Novartis scandal

                    TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, speaks in a press conference in Tokyo on Oct. 3, 2013. At right is Yoshiyasu Ninomiya, president of Novartis Pharma K.K., a Japanese unit of Novartis AG. Novartis Pharma K.K. has allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.
                      Novartis scandal

                      Novartis scandal

                      TOKYO, Japan - David Epstein (C), division head at Novartis AG, the Swiss-based pharmaceutical giant, and Yoshiyasu Ninomiya (R), president of Novartis Pharma K.K., a Japanese unit of Novartis AG, bow in apology during a press conference in Tokyo on Oct. 3, 2013. Novartis Pharma K.K. has allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.